JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms

• Waihay J. Wong,
• Robert P. Hasserjian,
• Geraldine S. Pinkus,
• Lawrence J. Breyfogle,
• Ann Mullally,
• Olga Pozdnyakova

Affiliations

Waihay J. Wong

Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA;Harvard Medical School, Boston, MA, USA

Robert P. Hasserjian

Harvard Medical School, Boston, MA, USA;Department of Pathology, Massachusetts General Hospital, Boston, MA, USA

Geraldine S. Pinkus

Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA;Harvard Medical School, Boston, MA, USA

Lawrence J. Breyfogle

Tufts University School of Medicine, Boston, MA, USA;Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA

Ann Mullally

Harvard Medical School, Boston, MA, USA;Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA

Olga Pozdnyakova

Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA;Harvard Medical School, Boston, MA, USA